Aging-associated non-melanoma skin cancer: A role for the dermis

Textbook of Aging Skin

Volumn , Issue , 2010, Pages 587-599

  Lewis, Davina A ^a   Travers, Jeffrey B ^a   Spandau, Dan F ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891992060     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-89656-2_58     Document Type: Chapter

References (117)

1. ACS Cancer Facts and Figures 2008.
2. Kripke ML. Carcinogenesis: Ultraviolet radiation. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in General Medicine. New York: McGraw-Hill, 1993; pp. 797-804.
3. Tyrrell RM. The molecular and cellular pathology of solar ultraviolet radiation. Molec Aspects of Med. 1994;15:1-77.
4. Clingen PH, Arlett CF, Roza L, Mori T, Nikaido O, Green MHL. Induction of cyclobutane pyrimidine dimers, pyrimidine(6-4) pyrimidone photoproducts, and dewar valence isomers by natural sunlight in normal human mononuclear cells. Cancer Res. 1995;55:2245-2248.
5. Wikonkal NM, Brash DE Ultraviolet radiation induced signature mutations in photocarcinogenesis J Invest Dermatol Symp Proc. 1999;4:6-10.
6. Brash DE, Heffernan T, Nghiem P. Carcinogenesis: Ultraviolet radiation. In: Wolff (ed) Fitzpatrick's Dermatology in General Medicine.
7. Kraemer KH. Sunlight and skin cancer: Another link revealed. Proc Natl Acad Sci USA. 1997;94:11-14.
8. Kuhn C, Kumar M, Hurwitz SA, Cotton J, Spandau DF. Activation of the insulin-like growth factor-1 receptor promotes the survival of human keratinocytes following ultraviolet B irradiation. Intl J Cancer. 1999;80:431-438.
9. Lewis DA, Spandau DF. UVB-induced activation of NF-kB is regulated by the IGF-1R and dependent on p38 MAPK. J Invest Dermatol. 2008;128:1022-1029.
10. Lewis DA, Yi Q, Travers JB, Spandau DF UVB-induced senescence in human keratinocytes requires a functional IGF-1R and p53.Mol Biol Cell. 2008;19:1346-1353.
11. Lewis DA, Travers JB, Spandau DF. A new paradigm for the role of aging in the development of skin cancer. J Invest Dermatol. 2008;129:787-791.
12. Lewis DA, Travers JB, Somani AK, Spandau DF. A new role for the dermis in aging-associated skin cancer. (under review) 2009.
13. Barreca A, De Luca M, Del Monte P, Bondanza S, Damonte G, Cariola G, et al. In vitro paracrine regulation of human keratinocyte growth by fibroblast derived insulin-like growth factors. J Cell Physiol. 1992;151:262-268.
14. Tavakkol A, Elder JT, Griffiths CE, Cooper KD, Talwar H, Fisher GJ, et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol. 1992;99:343-349.
15. Campisi J. Aging and cancer cell biology, 2008. Aging Cell. 2008; 7:281-284.
16. Vasto S, Carruba G, Lio D, Colonna-Romano G, Di Bona D, Candore G, Caruso C. Inflammation, ageing and cancer. Mech Ageing Develop. 2009;130:40-45.
17. Anisimov VN. Carcinogenesis and aging 20 years after. Escaping horizon. Mech Ageing Develop. 2009;130:105-121.
18. Moriwaki S, Ray S, Tarone RE, Kraemer KH, Grossman L. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: Reduced DNA repair capacity and increased DNA mutability. Mutat Res. 1996;364:117-123.
19. Ouhtit A, Ueda M, Nakazawa M, Dumaz N, Sarasin A, Yamasaki H. Quantitative detection of ultraviolet-specific p53 mutations in normal skin from Japanese patients. Cancer Epidemiol Biomarkers Prev. 1997;6:433-438.
20. Krtolica A, Parrinello S, Lockett S, Desprez P-Y, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci USA. 2001;98: 12072-12077.
21. Parrinello S, Coppe J-P, Krtolica A, Campisi J. Stromal-epithelial interactions in aging and cancer: Senescent fibroblasts alter epithelial cell differentiation. J Cell Sci. 2005;118:485-496.
22. Campisi J. Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell. 2005;120:513-522.
23. Jemal A, Tiwari RC, Murray T, et al. Cancer Statistics. CA Cancer J Clin. 2004;54:8-29.
24. Fuchs E, Raghavan S. Getting under the skin of epidermal morphogenesis. Nature Rev Genetics. 2002;31:199-209.
25. Mullenders LHF, Van Hoffen A, Vreeswijk MP, Gruven HJ. Vrieling, Van Zeeland H. Ultraviolet-induced photolesions: Repair and mutagenesis. Recent Results Cancer Res. 1997;143:89-99.
26. Yuspa SH, Dlugosz AA. Cutaneous carinogenesis: Natural and experimental. In: Goldsmith LA (ed) Physiology, Biochemistry and Molecular Biology of the Skin. New York: Oxford University Press, 1991, pp. 1365-1402.
27. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature Med. 2004;10:789-799.
28. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Stillman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JKV, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, KinzlerKW, Velculescu VE. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314:268-274.
29. Campisi J. Suppressing cancer: The importance of being senescent. Science. 2005;309:886-887.
30. Dimri GP. What has senescence got to do with cancer? Cancer Cell. 2005;7:505-512.
31. Feng Z, Hu W, Teresky AK, Hernando E, Cordon-Cardo C, Levine AJ. Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci USA. 2007;104:16633-16638.
32. Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutation Res. 2005;571:91-106.
33. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M. Fukunaga M, et al. UV-induced skin damage. Toxicology. 2003;189:21-37.
34. Melnikova VO, Ananthaswamy HN Cellular and molecular events leading to the development of skin cancer.Mut Res. 2005;571:91-106.
35. Nishigori C. Cellular Aspects of photocarcinogenesis. Photochem Photobio Sci. 2006;5:208-214.
36. Mathon NF, Lloyd AC. Cell senescence and cancer. Nat Rev Cancer. 2001;1:203-213.
37. Krtolica A, Campisi J. Cancer and aging: A model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol. 2002;34:1401-1414.
38. Campisi J. Cancer and ageing: Rival demons? Nat Rev Cancer. 2003;3:339-349.
39. Matsumura Y, Ananthaswammy HN. Toxic effects of ultraviolet radiation on the skin. Toxical Appl Pharmacol. 2004;195:298-308.
40. Ramos J, Villa J, Ruiz A, Armstrong R, Matta A. UV dose determines key characteristics of non-melanoma skin cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:2006-2011.
41. Brash DE. Roles of the transcription factor p53 keratinocyte carcinomas. Br J Dermatol. 2006;154:8-10.
42. Benjamin CL, Anathaswamy HN. p53 and the pathogenesis of skin cancer. Toxical Appl Pharmacol. 2007;224:241-248.
43. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, et al. Frequent clones of p53-mutated in keratinocytes in normal skin. Proc Natl Acad Sci USA. 1996;93:14025-14029.
44. Rodier F, Campisi J, Bhaumik D. Two faces of p53: Aging and tumor suppression. Nucleic Acids Res. 2007;35:7475-7484.
45. Halliday GM, Rana S. Wave band and dose dependency of sunlightinduced immunomodulation and cellular changes. Photochem Photobio. 2008;84:35-46.
46. Zhang Q, Yao Y, Konger RL, Sinn A, Cai S, Pollok KE, Travers JB. Platelet-activating factor mediates ultraviolet B radiation-mediated inhibition of delayed-type contact hypersensitivity reactions. J Invest Dermatol. 2008;128:1780-1787.
47. Aubin F. Mechanisms involved in ultraviolet light-induced immunesuppression. Eur J Derm. 2003;13:515-523.
48. Schwartz T. Photoimmunosupression. Photodermatol Photoimmunol Photomed. 2002;18:141-145.
49. Marathe GK, Johnson C, Billings SD, Southall MD, Pei Y, Spandau DF, Murphy RC, Zimmerman GA, McIntyre TM, Travers JB. Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. J Biol Chem. 2005; 280:35448-35457.
50. Halliday GM. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mut Res. 2005;571:107-120.
51. Chung JH, Hanft VN, Kang S. Aging and photoaging. J Am Acad Dermatol. 2003;49:690-697.
52. Cooper SJ, Bowen GT. Ultraviolet B regulation of transcription factor families: Role of the nuclear factor-kappa B (NF-kB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr Cancer Drug Targets. 2007;7:325-334.
53. Madson JG, Hansen LA. Multiple mechanisms of erbB2 action after ultraviolet irradiation of the skin. Mol Carcinog. 2007; 46:624-628.
54. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: A systematic review of epidemiologic studies. Cancer Causes Control. 2001;12:(2001), 69-82.
55. MacKie RM. Long-term health risk to the skin of ultraviolet radiation. Prog Biophys Mol Biol. 2006;92:92-96.
56. Feng Z, Hu W, Teresky AK, Hernando E, Cordon-Cardo C, Levine AJ. Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older population. Proc Natl Acad Sci USA. 2007;104:16633-16638.
57. Bickers DR, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol. 2006;126:2565-2575.
58. Chen J-H, Hales N, Ozanne SE. DNA damage, cellular senescence and organismal ageing: Causal or correlative. Nucleic Acids Res. 2007;35:7417-7428.
59. Bertram C, Hass R. Cellular responses to ROS-induced DNA damage and aging. Biol Chem. 2008;389:211-220.
60. Burhans WC, Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res. 2007;35:7545-7556.
61. Yamada M, Udono M, Hori M, Hirose R, Sato S, Mori T, et al. Aged human skin removes UVB-induced pryimidine dimers from the epidermis more slowly than younger adult skin in vivo. Arch Dermatol Res. 2006;297:294-302.
62. Kenyon J, Gerson SL. The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res. 2007;35:7557-7565.
63. Sunderkotter C, Kalden H, Luger TA. Aging and the skin immune system. Arch Dermatol. 1997;133:1256-1262.
64. Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol. 2007;211:144-156.
65. Witkowski JM, Soroczynska-Cybula M, Bryl E, Smolenska Z, Jozwik A. Klotho-a common link in physiological and rheumatoid arthritis related aging of human CD4 lymphocytes. J Immunol. 2007;178:771-777.
66. Hayflick L, Moorhead P. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:385-621.
67. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458-460.
68. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol. 2005;37:(2005), 961-976.
69. Blackburn EH. Telomeres and telomerase: Their mechanisms of action and the effects of altering their function. FEBS Lett. 2005; 579:859-862.
70. Herbig U, Jobling WA, Chen BPC, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through apathwya involving ATM, p53 and p21CIP1 but not p16INK4a. Mol Cell. 2004;14:501-513.
71. Dimiri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarkers that identifies senescent human cells in culture and in aging skin in vivo. Pro. Natl Acad Sci USA. 1995;92:9363-9367.
72. Herbig U, Ferreira M, Carey D, Sedivy JM. Cellular senescence in aging primates. Science. 2006;311:(2006), 1257.
73. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev. 2007;128:36-44.
74. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 1957;11:398-411.
75. Hornsby PJ. Senescence as an anticancer mechanism. J Clin Oncol. 2007;14:1852-1857.
76. Dilley T, Bowden G, Chen Q. Novel mechanisms of sublethal oxidant toxicity: Induction of premature senescence in human fibroblasts confer tumor promoter activity. Exp Cell Res. 2003;290: 38-48.
77. Collado M, Blasco MA, Serrao M. Cellular senescence in cancer and aging. Cell. 2007;130:223-231.
78. Sorrell JM, Baber MA, Caplan AI. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J Cell Physiol. 2004;200:134-145.
79. El-Ghalbzouri A, Gibbs S, Lamme E, Van Blitterswijk CA, Ponec M. Effect of fibroblasts on epidermal regeneration. Br J Dermatol. 2002;147:230-243.
80. Kneilling M, Rocken M. Mast cells: Novel clinical perspectives from recent insights. Exp Dermatol. 2009;18:488-496.
81. Sharp L, Jameson J Cauvi G, Havran W. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nature Immun. 2004;6:73-79.
82. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. Senescence associated secretory phenotypes reveal cell non-autonomous functions of oncogenic RAS and p53 tumor suppressor. PLoS. 2008;6:2853-2868.
83. Nolte SV, XuWeiguoW, Rennekampff HO, Rodemann HP. Diversity of fibroblasts-a review on implications for skin tissue engineering. Cell Tissues Organs. 2008;187:165-176.
84. Eming1 Sabine A, Krieg1 Thomas, Davidson Jeffrey M. Inflammation in wound repair: Molecular and cellular mechanisms. J Invest Dermatol. 2007;127:514-525.
85. Spiekstra SW, Breetveld M, Rustemeyer T, Scheper RJ, Gibbs S. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen. 2007; 15:708-717.
86. Haniffa MA, Wang XN, Holtick U, Rae M, Isaacs JD, Dickinson AM, Hilkens CMU, Collin MP. Adult Human Fibroblasts Are Potent immunoregulatory Cells and functionally equivalent to mesenchymal stem cells. J Immun. 2007;179:1595-1604.
87. Flavell SJ, Hou TZ, Lax AD, Salmon M, Buckley CD. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharm. 2008;153:s241-s246.
88. Campisi J, Fagagna F. Cellular senescence: When bad things happen to good cells. Mol Cell Biol. 2007;8:729-740.
89. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298-300.
90. Sohal RS, Orr WC. Oxidative stress may be a causal factor in senescense. Age. 1998;21:81-82.
91. Hamilton ML, Remmen HV, Drake JA, Yang H, Guo ZM, Kewitt K, Walter CA, Richardson A. Does oxidative damage to DNA increase with agé. Proc Natl Acad Sci USA. 2001;98:10469-10474.
92. Lin MT, Flint BM. The oxidative theory of aging. Clin Neuroscience Res. 2003;2:305-315.
93. Shelton DN, Chang E, Whittier PS, Choi D, Funk WD. Microarray analysis of replicative senescence. Current Bio. 1999; 9:939-945.
94. Wall IB, Moseley R, Briard DM, Kipling D, Giles P, Laffafian I, et al. Fibroblast dysfunction is a key factor in non-healing of chronic venous leg ulcers. J Invest Dermatol. 2008;128:2526-2540.
95. Farage MA, Miller KW, Elsner P, Maibach HI. Intrinsic and extrinsic factors in aging: A review. Int J Cosmetic Sci. 2008; 30:87-95.
96. Bol DK, Kigucji K, Gimenez-Conti I, Rupp T, DiGiovanni J. Overexpression of the insulin-like growth factor-1 induces hyperplasia, dermal abnormalities and spontaneous tumor formation in transgenic mice. Oncogene. 1997;14:1725-1734.
97. Wilker E, Bol D, Kiguchi K, Rupp T, Beltran L, Di Giovanni J. Enhancement for susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice. Mol Carcinog. 1999;25:122-131.
98. DiGiovanni J, Bol DK, Wilker E, Beltran L, Carbajal S, Moats S, et al. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res. 2000;60:1561-1570.
99. Sadagurski M, Yakar S, Weingarten G, Holzenberger M, Rhodes C, Breikreutz D, et al. Insulin-like growth factor receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol Cell Biol. 2006;26:2675-2687.
100. Lin K, Hsin H, Libina N, Kenyon C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF1 and germline signaling. Nat Genet. 2001;28:139-145.
101. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003;21:182-187.
102. Kruso H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309:1829-1833.
103. Ikushima M, Rakugi H, Ishidawa K, Maedawa Y. YamamotoK, Ohta J, et al. Anti-apoptotic and anti-senescent effects of Klotho on vascular endothelial cells. Biochem Biophys Res Commun. 2006;339:827-832.
104. Chuang T-Y, Lewis DA, Spandau DF. Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: A pilot study. Br J Dermatol. 2005;153:552-557.
105. Ferber A, Chang C, Sells C, Ptasznik A, Cristofalo V, Hubbard K, et al. Failure of senescent human fibroblasts to express insulin-like growth factor-1 gene. J Biol Chem. 1993;268:17883-17888.
106. Pollak M. Insulin and insulin-like growth factor signaling in neoplasia. Nature Rev Cancer. 2008;8:915-928.
107. Lann D, LeRoith D. The role of endocrine insulin-like growth factor-1 and insulin in breast cancer. J Mammary Gland Biol Neoplasia. 2008;13:371-379.
108. Dziadziuszko R, Camidge DR, Hirsch FR. The insulin-like growth factor in lung cancer. J Thorac Oncol. 2008;3:815-818.
109. Donovan EA, Kummar S. Role of the insulin-like growth factor-1R system in colorectal carcinogenesis. Critical Rev Oncol-Hematol. 2008;66:91-98.
110. Thompson SC, Jolley D, Marks R. Reduction of solar keratosis by regular sunscreen use. New Eng J Med. 1993;329:1147-1151.
111. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks G, Gaffney P, Battistath D, Frost C, Lang C, Russell A. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomized controlled trial. Lancet. 1999;354:723-729.
112. Neale R, Williams G, Green A. Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch Dermatol. 2002;138:1319-1325.
113. Gold MH, Nestor MS. Current treatments of actinic keratosis. J Drugs Dermatol. 2006;5(Suppl 2): 17-25.
114. Meshkinpour A, Ghasri P, Pope K, Lyubovitsky JG, Risteli J, Krasieva TB, Kelly KM. Treatment of hypertrophic scars and keloids with a radiofrequency device: A study of collagen effects. Lasers Surg Med. 2005;37:343-349.
115. DeHoratius DM, Dover JS. Nonablative tissue remodeling and photorejuvenation. Clin Dermatol. 2007;25:474-479.
116. Sachs DL, Kang S, Hammerberg C, Helfrich Y, Karimipour D, Orringer J, Johnson T, Hamilton TA, Fisher G, Voorhees JJ. Topical fluorouracil for actinic keratoses and photoaging: A clinical and molecular analysis. Arch Dermatol. 2009;145:659-666.
117. Collett-Solberg PF, Misra M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. The role of recombinant human insulin-like growth factor-I in treating children with short stature. J Clin Endocrin Metabol. 2008;93:10-18.